The Pharma Data

DECEMBER 17, 2020

17, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. Have chronic kidney disease. Have immunosuppressive disease. cardiovascular disease, OR. chronic obstructive pulmonary disease/other chronic respiratory disease. sickle cell disease, OR. congenital or acquired heart disease, OR.

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

JANUARY 12, 2021

Regeneron Pharmaceuticals, Inc. Have chronic kidney disease. Have immunosuppressive disease. cardiovascular disease, OR. chronic obstructive pulmonary disease/other chronic respiratory disease. sickle cell disease, OR. congenital or acquired heart disease, OR. Have diabetes. 65 years of age.

Government 52

Government Hospitals Virus Production 52

The Pharma Data

DECEMBER 29, 2020

Regeneron Pharmaceuticals, Inc. 35 — Have chronic kidney disease — Have diabetes — Have immunosuppressive disease — Are currently receiving immunosuppressive treatment — Are ?65 cardiovascular disease, OR. chronic obstructive pulmonary disease/other chronic respiratory disease.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

The Pharma Data

NOVEMBER 20, 2020

November 21, 2020 – Regeneron Pharmaceuticals, Inc. The FDA grants Emergency Use Authorization to medicines that may help diagnose, treat or prevent a life-threatening disease when adequate and approved alternatives are not available. Have chronic kidney disease. Have immunosuppressive disease.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

NOVEMBER 21, 2020

Regeneron Pharmaceuticals, Inc. The FDA grants Emergency Use Authorization to medicines that may help diagnose, treat or prevent a life-threatening disease when adequate and approved alternatives are not available. Have chronic kidney disease. Have immunosuppressive disease. cardiovascular disease, OR.

FDA 40

FDA Clinical Trials Hospitals Government 40

The Pharma Data

DECEMBER 31, 2020

Centers for Disease Control and Prevention — could be somewhat low. Right now, most shots are being given at hospitals, clinics and nursing homes, but Perna and Slaoui agreed that the pace of vaccination should pick up considerably once doses are given out by the major pharmacy chains. million, the Times said.

Vaccine 52

Vaccine Long-Term Care Facilities Virus Hospitals 52

Drug & Device Law

DECEMBER 29, 2023

Infectious Diseases Society of America , 86 F.4th 2023) (HHS cannot force pharmaceutical manufacturers to sell unlimited amounts of prescription drugs at a discount) ( here ). That meant both the pharmacist and the pharmacy where the vaccine was administered “covered persons” under the act. Forest Pharmaceuticals, Inc.

Testimonials 105

Testimonials FDA Drugs Vaccine 105